Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02437669 · ClinicalTrials.gov registry record · Phase 2
Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.
A Phase 2 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT02437669 is a Phase 2 study that has completed, run by Columbia University. The registered enrollment target is 35 participants.
The verdict
NCT02437669, a Phase 2 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
Intranasal hydromorphone has been shown to be effective in reducing acute pain in adults. It has not been previously studied in children, but may be a viable option for effectively and safely reducing pain in children by administering an analgesic by the intranasal route. This study will be a prospective, open-label pilot study of intranasal hydromorphone in children with moderate to severe acute pain presenting to the pediatric emergency department. The investigators aim to describe the amount of pain reduction associated with intranasal hydromorphone, and to determine the optimal dose of intranasal hydromorphone associated with a clinically meaningful improvement in acute pain.
Interventions
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02437669
The ClinicalTrials.gov registry entry for NCT02437669 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydromorphone is the first listed.
NCT02437669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02437669 about?
NCT02437669 is a clinical study titled "Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.". Intranasal hydromorphone has been shown to be effective in reducing acute pain in adults. It has not been previously studied in children, but may be a viable option for effectively and safely reducing pain in children by administering an analgesic by the intranasal route. This study will be a prosp...
What is the current status of trial NCT02437669?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2015-05. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02437669?
The interventions under investigation include: Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT02437669?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.